Trials / Completed
CompletedNCT01753349
Phase IV-Cervical Dystonia-INTEREST IN CD2
An International Observational Prospective Study On Long-Term Response To Botulinum Toxin Type A (BoNT-A) Injections In Subjects Suffering From Idiopathic Cervical Dystonia (CD) - Pharmaco-Economic Impact
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,050 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to document long-term response in real-life practice after injection cycles with BoNT-A in subjects suffering from idiopathic cervical dystonia (Long-term clinical and pharmaco-economic data).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum toxin type A | Investigators were free to prescribe any BoNT A preparation, including Dysport, Botox and Xeomin. |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-25
- First posted
- 2012-12-20
- Last updated
- 2020-11-05
Locations
113 sites across 34 countries: United States, Algeria, Australia, Austria, Belgium, Brazil, China, Czechia, Estonia, France, Germany, Hungary, Israel, Italy, Jordan, Latvia, Lebanon, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Russia, Serbia, Singapore, Slovenia, South Korea, Sweden, Taiwan, Thailand, Turkey (Türkiye), United Arab Emirates, United Kingdom
Source: ClinicalTrials.gov record NCT01753349. Inclusion in this directory is not an endorsement.